Even a lousy deal will be multiples of current price but ask yourself, after (el) Dorado, are they likely to get a lousy deal?
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025